Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
FICO
|
William J Lansing
President and CEO |
SELL
Open market or private sale
|
Direct | 28,462 Reduced 14.98% |
$12,123,104
$425.94 p/Share
|
Sep 30
2020 |
MORN
|
Joseph D Mansueto
Executive Chairman |
SELL
Open market or private sale
|
Direct | 12,756 Reduced 0.06% |
$2,046,828
$160.46 p/Share
|
Sep 30
2020 |
CHK
|
William M Buergler
SVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 591 Reduced 99.66% |
$2,482
$4.2 p/Share
|
Sep 30
2020 |
DXCM
|
Steven Robert Pacelli
EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 3.07% |
$821,380
$410.69 p/Share
|
Sep 30
2020 |
FND
|
Brian K Robbins
EVP - BUS. DVLPMT, STRATEGY |
SELL
Open market or private sale
|
Direct | 10,813 Reduced 24.77% |
$812,597
$75.15 p/Share
|
Sep 30
2020 |
GNTX
|
Steven R Downing
President and CEO |
SELL
Open market or private sale
|
Direct | 6,000 Reduced 4.31% |
$154,860
$25.81 p/Share
|
Sep 30
2020 |
GNTX
|
Kevin C Nash
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 9.08% |
$77,430
$25.81 p/Share
|
Sep 30
2020 |
AXON
|
Matthew R Mcbrady |
SELL
Open market or private sale
|
Direct | 350 Reduced 3.79% |
$31,689
$90.54 p/Share
|
Sep 30
2020 |
COUP
|
Todd R Ford
President & CFO, Emeritus |
SELL
Open market or private sale
|
Direct | 12,500 Reduced 51.05% |
$3,432,125
$274.57 p/Share
|
Sep 30
2020 |
AQUA
|
James M. Kohosek
EVP, Chief Admin. Officer |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 31.29% |
$645,000
$21.5 p/Share
|
Sep 30
2020 |
MMS
|
Bruce Caswell
CEO & President |
SELL
Open market or private sale
|
Direct | 23,303 Reduced 16.63% |
$1,594,158
$68.41 p/Share
|
Sep 30
2020 |
MMS
|
Ilene R. Baylinson
General Mgr - Health & Human |
SELL
Open market or private sale
|
Direct | 8,852 Reduced 32.76% |
$605,565
$68.41 p/Share
|
Sep 30
2020 |
MMS
|
Richard A Montoni
Director |
SELL
Open market or private sale
|
Direct | 11,639 Reduced 5.14% |
$796,224
$68.41 p/Share
|
Sep 30
2020 |
MMS
|
Richard John Nadeau
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 4,365 Reduced 15.03% |
$298,610
$68.41 p/Share
|
Sep 30
2020 |
MMS
|
Thomas D. Romeo
Group General Manager |
SELL
Open market or private sale
|
Direct | 6,257 Reduced 27.82% |
$428,041
$68.41 p/Share
|
Sep 30
2020 |
MMS
|
Michelle F. Link
Chief of Human Resources |
SELL
Open market or private sale
|
Direct | 495 Reduced 45.12% |
$33,863
$68.41 p/Share
|
Sep 30
2020 |
MMS
|
David Francis
General Counsel |
SELL
Open market or private sale
|
Direct | 6,246 Reduced 27.22% |
$427,289
$68.41 p/Share
|
Sep 30
2020 |
AMED
|
Scott G Ginn
EVP, CFO & COO |
SELL
Open market or private sale
|
Direct | 975 Reduced 4.87% |
$225,020
$230.79 p/Share
|
Sep 30
2020 |
AYX
|
Robert Scott Jones
Pres. & Chief Revenue Officer |
SELL
Open market or private sale
|
Direct | 4,167 Reduced 9.56% |
$470,038
$112.8 p/Share
|
Sep 30
2020 |
ASAN
|
Matt Cohler
Director |
SELL
Open market or private sale
|
Indirect | 761,087 Reduced 3.75% |
$21,462,654
$28.2 p/Share
|
Sep 30
2020 |
ASAN
|
Steven M Spurlock
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 761,087 Reduced 3.75% |
$21,462,654
$28.2 p/Share
|
Sep 30
2020 |
ASAN
|
Benchmark Capital Management Co. Vi, L.L.C.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 761,087 Reduced 3.75% |
$21,462,654
$28.2 p/Share
|
Sep 30
2020 |
ASAN
|
Justin Rosenstein
Director |
SELL
Open market or private sale
|
Direct | 1,150,000 Reduced 48.12% |
$32,280,500
$28.07 p/Share
|
Sep 30
2020 |
ASAN
|
Tim M Wan
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 80,000 Reduced 17.85% |
$2,260,800
$28.26 p/Share
|
Sep 30
2020 |
ASAN
|
Chris Farinacci
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 318,019 Reduced 64.5% |
$8,984,037
$28.25 p/Share
|
Sep 30
2020 |
ASAN
|
Dustin A. Moskovitz
President, CEO, & Chair |
SELL
Open market or private sale
|
Direct | 200,000 Reduced 20.0% |
$5,400,000
$27.0 p/Share
|
Sep 30
2020 |
ASAN
|
Dustin A. Moskovitz
President, CEO, & Chair |
SELL
Open market or private sale
|
Indirect | 700,000 Reduced 5.46% |
$19,607,000
$28.01 p/Share
|
Sep 30
2020 |
FOLD
|
Jay Barth
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 4,064 Reduced 2.43% |
$58,969
$14.51 p/Share
|
Sep 30
2020 |
MC
|
Elizabeth Crain |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 30.55% |
$525,000
$35.0 p/Share
|
Sep 30
2020 |
PGNY
|
Norman Payson
Director |
SELL
Open market or private sale
|
Indirect | 16,500 Reduced 0.52% |
$490,380
$29.72 p/Share
|
Sep 30
2020 |
CARG
|
Langley Steinert
Executive Chair |
SELL
Open market or private sale
|
Direct | 12,006 Reduced 1.2% |
$260,530
$21.7 p/Share
|
Sep 30
2020 |
CARG
|
Langley Steinert
Executive Chair |
SELL
Open market or private sale
|
Indirect | 987 Reduced 0.87% |
$21,418
$21.7 p/Share
|
Sep 30
2020 |
NEOG
|
James L Herbert
Director |
SELL
Open market or private sale
|
Direct | 25,333 Reduced 37.65% |
$1,991,427
$78.61 p/Share
|
Sep 30
2020 |
BBIO
|
Cameron Turtle
Officer |
SELL
Open market or private sale
|
Direct | 14,500 Reduced 53.57% |
$549,840
$37.92 p/Share
|
Sep 30
2020 |
NX
|
Susan F Davis
Director |
SELL
Open market or private sale
|
Direct | 2,290 Reduced 8.34% |
$43,212
$18.87 p/Share
|
Sep 30
2020 |
BIG
|
Wendy Lee Schoppert
Director |
SELL
Open market or private sale
|
Direct | 7,254 Reduced 36.18% |
$342,171
$47.17 p/Share
|
Sep 30
2020 |
YEXT
|
Tom Christopher Dixon
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 2.57% |
$38,375
$15.35 p/Share
|
Sep 30
2020 |
BAND
|
Douglas A Suriano
Director |
SELL
Open market or private sale
|
Direct | 234 Reduced 4.2% |
$41,161
$175.9 p/Share
|
Sep 30
2020 |
TLYS
|
Seth R Johnson
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 10.88% |
$60,500
$6.05 p/Share
|
Sep 30
2020 |
INFU
|
Thomas Mark Ruiz
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 64,745 Reduced 98.53% |
$773,703
$11.95 p/Share
|
Sep 30
2020 |
AKTS
|
Jeffrey B. Shealy
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 3.15% |
$419,500
$8.39 p/Share
|
Sep 30
2020 |
UAVS
|
Barrett Mooney
Chairman and CEO |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 16.67% |
$44,400
$2.22 p/Share
|
Sep 30
2020 |
ITRM
|
Judith M. Matthews
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 56,130 Reduced 100.0% |
$92,053
$1.64 p/Share
|
Sep 30
2020 |
EIDX
|
Uma Sinha
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 169 Reduced 0.05% |
$8,795
$52.04 p/Share
|
Sep 30
2020 |
TSLA
|
Kathleen Wilson Thompson
Director |
SELL
Open market or private sale
|
Direct | 12,500 Reduced 87.41% |
$5,334,125
$426.73 p/Share
|
Sep 30
2020 |
PLTR
|
Peter Thiel
Director |
SELL
Open market or private sale
|
Indirect | 23,013,764 Reduced 37.84% |
$247,397,963
$10.75 p/Share
|
Sep 30
2020 |
DEN
|
Goldentree Asset Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 106 Reduced 0.0% |
$1,908
$18.0 p/Share
|
Sep 30
2020 |
ATAO
|
Erop Capital LLC |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 0.02% |
$1,760
$0.22 p/Share
|
Sep 30
2020 |
SSNT
|
Jeffrey D Roth
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 6,897 Reduced 1.4% |
$18,277
$2.65 p/Share
|
Sep 30
2020 |
COST
|
Joseph P Portera
Executive VP |
SELL
Open market or private sale
|
Indirect | 6,000 Reduced 50.74% |
$2,088,000
$348.0 p/Share
|
Sep 29
2020 |